Universal-Beteiligungs- und Servicegesellschaft’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.26M Buy
259,187
+24,292
+10% +$797K 0.01% 726
2025
Q4
$8.79M Buy
234,895
+116
+0% +$3.81K 0.01% 657
2025
Q3
$6.47M Buy
234,779
+66,236
+39% +$2.28M 0.01% 761
2025
Q2
$5.33M Buy
168,543
+15,217
+10% +$490K 0.01% 811
2025
Q1
$5.09M Buy
153,326
+59,315
+63% +$2.13M 0.01% 794
2024
Q4
$3.23M Buy
+94,011
New +$3.23M 0.01% 817

Other funds holding HRMY

Universal-Beteiligungs- und Servicegesellschaft's HRMY Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Harmony Biosciences (HRMY) stake by 10% in Q1 2026, buying an estimated $797K and bringing the position to 259,187 shares worth $7.26M. The position accounts for 0.01% of the portfolio, ranked #726.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in HRMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.79M in Q4 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 259,187 shares of Harmony Biosciences worth $7.26M as of Q1 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 24,292 Harmony Biosciences shares in Q1 2026, an estimated $797K.
  • Harmony Biosciences made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #726 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Harmony Biosciences in Q4 2024 and has held it in 6 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Harmony Biosciences position peaked at $8.79M in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.